Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects

This study has been completed.
Sponsor:
Collaborators:
Kinesis Pharma
CEVAC
M.A.R.C.O.
Mouton's Safety Consultancy
Pharmafour
Pevion
Chimera
Institute Cochin
San Raffaele University Hospital, Italy
INSERM UMR 721
Information provided by:
Mymetics Corporation
ClinicalTrials.gov Identifier:
NCT01084343
First received: March 9, 2010
Last updated: July 12, 2012
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
No publications provided by Mymetics Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):